Displaying 20 results from an estimated 83 matches for "efficacy".
2018 Aug 10
4
Efficacy of jitterentropy RNG on qemu-kvm Guests
Hello. I'm a distro maintainer and was wondering about the efficacy of
entropy daemons like haveged and jitterentropyd in qemu-kvm. One of the
authors of haveged [0] pointed out if the hardware cycles counter is
emulated and deterministic, and thus predictible. He therefore does not
recommend using HAVEGE on those systems. Is this the case with KVM's
counters?...
2018 Aug 16
1
Re: Efficacy of jitterentropy RNG on qemu-kvm Guests
Martin Kletzander:
> On Fri, Aug 10, 2018 at 08:33:00PM +0000, procmem wrote:
>> Hello. I'm a distro maintainer and was wondering about the efficacy of
>> entropy daemons like haveged and jitterentropyd in qemu-kvm. One of the
>> authors of haveged [0] pointed out if the hardware cycles counter is
>> emulated and deterministic, and thus predictible. He therefore does not
>> recommend using HAVEGE on those systems. Is thi...
2018 Aug 16
0
Re: Efficacy of jitterentropy RNG on qemu-kvm Guests
On Fri, Aug 10, 2018 at 08:33:00PM +0000, procmem wrote:
>Hello. I'm a distro maintainer and was wondering about the efficacy of
>entropy daemons like haveged and jitterentropyd in qemu-kvm. One of the
>authors of haveged [0] pointed out if the hardware cycles counter is
>emulated and deterministic, and thus predictible. He therefore does not
>recommend using HAVEGE on those systems. Is this the case with KVM&...
2018 Aug 16
0
Re: Efficacy of jitterentropy RNG on qemu-kvm Guests
On Fri, Aug 10, 2018 at 08:33:00PM +0000, procmem wrote:
> Hello. I'm a distro maintainer and was wondering about the efficacy of
> entropy daemons like haveged and jitterentropyd in qemu-kvm. One of the
> authors of haveged [0] pointed out if the hardware cycles counter is
> emulated and deterministic, and thus predictible. He therefore does not
> recommend using HAVEGE on those systems. Is this the case with...
2011 Aug 04
1
Multiple endpoint (possibly group sequential) sample size calculation
Hello everyone,
I need to do a sample size calculation. The study two arms and two endpoints. The two arms are two different cancer drugs and the two endpoints reflect efficacy (based on progression free survival) and toxicity.
Until now, I have been trying to understand this in terms of a one-arm design, where the acceptable rate of efficacy might be 0.40, the unacceptable rate of efficacy might be 0.20, the acceptable rate of non-toxicity might be 0.85, and the unacce...
2002 Feb 08
3
Plotting multiple columns on same graph
I'd like to produce a series of simple line graphs for my methods class
that show the three questions used on a repeated survey to make up a
particular index. The data frame is:
> efficacy.df
year complicated havesay dontcare
1 1952 71 68 63
2 1954 NA NA NA
3 1956 64 71 71
4 1958 NA NA NA
5 1960 59 72 73
6 1962 NA NA NA
7 1964 67 70 62...
2009 Sep 06
2
[LLVMdev] should we stop using llvm-as/llvm-dis in tests?
...Should we go through and update the existing tests?
>
> Yes, I think that Dan is planning to do this.
... and it is definitely worth doing. On my system a 'time' of make
check reports that about 50% of the real time running make check is
spent in the OS. This probably also limits the efficacy of attempts to
parallelize the test suite, if someone was crazy enough to do that.
Using opt -S for tests that end up going to llvm-dis would also be nice.
- Daniel
2010 Oct 06
5
How do you ensure safety from errors/bugs in large deployments?
Hello all,
This is not a puppet proper issue of course.. but I was wondering if
any of you could share some thoughts...
When you deploy a system like Puppet at a large park of systems, you
instantly increase the efficacy of mistakes and bugs in destroying the
environment....
How do you deal with that? I would be interested in any experience or
input, especially puppet proper best practices...
BTW, does puppet have any means to say something like "don''t ever do
anything that takes more than 5 minutes?...
2008 Jan 08
0
PwrGSD
...0.4332, 0.652, 0.6524, 0.6527, 0.653, 0.6534, 0.6537,
0.6541, 0.6544, 0.6547, 0.6551, 0.6554)
hc <- c(rep(1.05e-02, 2), rep(2.09e-02, 3), rep(4.19e-02, 15))
hd1B <- c(0.1109, 0.1381, 0.1485, 0.1637, 0.2446, 0.2497, 0)
test.example <- PwrGSD(
EfficacyBoundary=LanDemets(alpha=0.05, spending= ObrienFleming),
FutilityBoundary=LanDemets(alpha=0.1,spending=ObrienFleming),
RR.Futility = 0.82, sided="<",method="A",accru =7.73, accrat=9818.65,
tlook =tlook, tcut0 =t0, h0=h0, tcut1=t0, rhaz=rhaz,...
2008 Jan 08
0
PwrGSD
...0.4332, 0.652, 0.6524, 0.6527, 0.653, 0.6534, 0.6537,
0.6541, 0.6544, 0.6547, 0.6551, 0.6554)
hc <- c(rep(1.05e-02, 2), rep(2.09e-02, 3), rep(4.19e-02, 15))
hd1B <- c(0.1109, 0.1381, 0.1485, 0.1637, 0.2446, 0.2497, 0)
test.example <- PwrGSD(
EfficacyBoundary=LanDemets(alpha=0.05, spending= ObrienFleming),
FutilityBoundary=LanDemets(alpha=0.1,spending=ObrienFleming),
RR.Futility = 0.82, sided="<",method="A",accru =7.73, accrat=9818.65,
tlook =tlook, tcut0 =t0, h0=h0, tcut1=t0, rhaz=rhaz,...
2009 Sep 06
0
[LLVMdev] should we stop using llvm-as/llvm-dis in tests?
...date the existing tests?
>>
>> Yes, I think that Dan is planning to do this.
>
> ... and it is definitely worth doing. On my system a 'time' of make
> check reports that about 50% of the real time running make check is
> spent in the OS. This probably also limits the efficacy of attempts to
> parallelize the test suite, if someone was crazy enough to do that.
Why would be crazy to run the test suite on parallel? Because DejaGNU
limitations?
My compiler's test suite is driven by a poor-man's version of DejaGNU
(also written on Tcl, but not requiring Expect)...
2009 Sep 08
0
Genentech Nonclinical Biostatistics Position in South San Francisco
...reclinical testing, process and product development,
manufacturing, and quality control, among other areas - essentially
everything but clinical trials. Statistical activities are commensurately
diverse. Some "typical" ones are design and analysis of in vitro and in vivo
studies exploring efficacy, pharmacokinetics, and toxicity; design and
analysis of high-throughput experiments including genomic, proteomic, and
imaging platforms; bioanalytical assay development; optimization of robust
antibody fermentation and purification processes; and statistical support to
ensure compliance, safety, an...
2004 Jan 27
0
help help help
Hi,
I have a problem....
I need help about Generalized Estimating Equation. The response variable is "efficacy" (numeric) and the predictors are "eziology" (categoric) and "terapy" (string).
After downloaded the gee from CRAN I tried to use this procedure for example:
summary(gee(efficacy~eziology+terapy, id=?, data=pippo, corstr="exchangeable"))
Could you send me an exa...
2011 May 31
2
OT: Pie charts
...regularly get questions about making pie charts, and frequently
veer off into the philosophical and practical issues surrounding that
form of data graphic: human perception of angles and so on.
So while this isn't an R issue, I thought some of you might appreciate
this brief discussion of the efficacy of pie charts:
http://fakescience.tumblr.com/post/6042293374/understanding-pie-charts
Sarah
--
Sarah Goslee
http://www.functionaldiversity.org
2007 Jan 25
1
summary of the effects after logistic regression model
Dear all, my aim is to estimate the efficacy over time of a treatment for
headache prevention. Data consist of long sequences of repeated binary
outcomes (1 if the subject has at least 1 episode of headache , 0
otherwise) on subjects randomized to placebo or treatment.
I have fit a logistic regression model with Huber-White cluster sand...
2016 Mar 20
2
[GSoC 2016] Need more info on Add a MachineModulePass
...d. Examples of such applications include inter-procedural
register allocation, inter-procedural instruction selection,
inter-procedural code layout optimization (I have a colleague working on
this using reference affinity theory), and inter-procedural analysis of
machine code for measuring the efficacy of compiler transformations for
security.
Whether one keeps the LLVM IR around or not is orthogonal. What is
needed is a way of being able to examine the whole program without
having to worry about another transformation running in parallel (if you
use a MachineFunctionPass, as I understand i...
2009 Jul 20
0
Vacancy - PhD / Post-doctoral position at the University of Leiden.
...n priority medicines. Among
the various working groups, a research program has been started to
evaluate biomarkers and disease progression in COPD using longitudinal
models. The primary scope of this investigation is to establish which
markers of disease have predictive value for the outcome of efficacy
trials. Subsequently, modelling will be used to optimise clinical trial
design and characterise the relevance of different clinical trial factors
and procedures on study power, bias and treatment effect size.
Translational aspects will also be explored to allow better extrapolation
from precli...
2003 Apr 12
5
rpart vs. randomForest
Greetings. I'm trying to determine whether to use rpart or randomForest
for a classification tree. Has anybody tested efficacy formally? I've
run both and the confusion matrix for rf beats rpart. I've looking at
the rf help page and am unable to figure out how to extract the tree.
But more than that I'm looking for a more comprehensive user's guide
for randomForest including the benefits on using it with MD...
2006 Sep 27
4
An option to test what will be done by the puppet client?
Hi,
I can''t find an option of the puppetd client that can just print what
the puppetd client will do on my system (updateing files, installing
softwares, etc), but without doing all the things (like a "diff"
between the current state of my system and the state defined on the
puppet server).
Is such option exists ?
Regards
2008 Nov 10
0
Postdoc Positions Available at Leiden University The Netherlands
...looking for two highly motivated scientists (PhD degree) to:
1) investigate disease models in COPD. The COPD project is part
of the disease progression working group which consist of two PhD
students and two post-doctoral research fellows.
2) evaluate the "operational" efficacy of drugs that have been
identified to produce QTc-interval prolongation in early clinical
development. The translational research working group will focus on
cardiovascular safety, schizophrenia and neuropathic pain. This working
group consists in total of six PhD students and two post-doctoral
fel...